for Project III Voltage-gated sodium channels (VGSCs) are responsible for the action potential in nerve and muscle. VGSCs are typically comprised of one ?-subunit and one or more ?-subunits. Mammalian neurons can have seven kinds (or isoforms) of ?-subunits and four isoforms of ?-subunits, which give rise to a large assortment of possible ?/?-combinations or subtypes. Furthermore, a given neuron can have more than one subtype of VGSCs, where a given subtype may be localized to particular parts of the neuron. This diversity presents a serious challenge to the study of these channels and the development of drugs that target them. Drugs (such as local anesthetics) and toxins (such as tetrodotoxin, TTX) that block VGSCs have been mainstays in pain medication and basic neuroscience research. With notable exceptions, these small molecules do not discriminate readily among the various subtypes of VGSCs. For example, TTX is a very potent but indiscriminate blocker of most of the VGSC subtypes found in brain neurons. In contrast, conopeptides that target VGSCs can distinguish among neuronal subtypes. This proposal aims to exploit such conopeptides. There are four known families of conopeptides that target VGSCs, wherein members in each family have a characteristic structural framework and mechanism of action. It was recently discovered that members of two of these families could discriminate among VGSCs that had the same ?-subunit but different ?-subunits. This observation is unprecedented, and this proposal will: 1) examine the mechanism(s) underlying how ?-subunits influence conopeptide-susceptibility;2) determine whether ?-subunits also affect the activity of members of the other two families of conopeptides, and if so, how;3) develop conopeptides with sharper VGSC-subtype specificities. Finally, a new family of conopeptides, with an amino acid sequence unrelated to any previously characterized conopeptide, has been discovered that blocks most VGSCs provided that they do not have either a ?2- or ?4-subunit;the mechanism of action of this peptide will be investigated. This study will mainly entail electrophysiological experiments on VGSCs exogenously expressed in X. laevis oocytes and VGSCs endogenously expressed in neurons of rodent dorsal root ganglia.

Public Health Relevance

for Project III Malfunctioning VGSCs have been implicated in a variety of neurological disorders ranging from epilepsy to pain syndromes, and the long-term goal of this project is to use conopeptides to obtain insights into, and potential new drugs for, the treatment of such disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
2P01GM048677-21A1
Application #
8740927
Study Section
Special Emphasis Panel (ZRG1-MDCN-G (40))
Project Start
Project End
Budget Start
2014-09-10
Budget End
2015-07-31
Support Year
21
Fiscal Year
2014
Total Cost
$330,452
Indirect Cost
$108,672
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Richter, K; Mathes, V; Fronius, M et al. (2016) Phosphocholine - an agonist of metabotropic but not of ionotropic functions of α9-containing nicotinic acetylcholine receptors. Sci Rep 6:28660
Safavi-Hemami, Helena; Li, Qing; Jackson, Ronneshia L et al. (2016) Rapid expansion of the protein disulfide isomerase gene family facilitates the folding of venom peptides. Proc Natl Acad Sci U S A 113:3227-32
Green, Brad R; Gajewiak, Joanna; Chhabra, Sandeep et al. (2016) Structural Basis for the Inhibition of Voltage-gated Sodium Channels by Conotoxin μO§-GVIIJ. J Biol Chem 291:7205-20
Hone, Arik J; McIntosh, J Michael; Rueda-Ruzafa, Lola et al. (2016) Therapeutic concentrations of varenicline in the presence of nicotine increase action potential firing in human adrenal chromaffin cells. J Neurochem :
Espino, Samuel S; Dilanyan, Taleen; Imperial, Julita S et al. (2016) Glycine-rich conotoxins from the Virgiconus clade. Toxicon 113:11-7
Zuo, Wanhong; Xiao, Cheng; Gao, Ming et al. (2016) Nicotine regulates activity of lateral habenula neurons via presynaptic and postsynaptic mechanisms. Sci Rep 6:32937
Curtice, Kigen J; Leavitt, Lee S; Chase, Kevin et al. (2016) Classifying neuronal subclasses of the cerebellum through constellation pharmacology. J Neurophysiol 115:1031-42
Yorgason, J T; Rose, J H; McIntosh, J M et al. (2015) Greater ethanol inhibition of presynaptic dopamine release in C57BL/6J than DBA/2J mice: Role of nicotinic acetylcholine receptors. Neuroscience 284:854-64
Lee, Hee-Kyoung; Zhang, Liuyin; Smith, Misty D et al. (2015) A marine analgesic peptide, Contulakin-G, and neurotensin are distinct agonists for neurotensin receptors: uncovering structural determinants of desensitization properties. Front Pharmacol 6:11
Aman, Joseph W; Imperial, Julita S; Ueberheide, Beatrix et al. (2015) Insights into the origins of fish hunting in venomous cone snails from studies of Conus tessulatus. Proc Natl Acad Sci U S A 112:5087-92

Showing the most recent 10 out of 238 publications